Renaissance Technologies (RenTech)'s GUTS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 10,183 shares of Fractyl Health, Inc. (GUTS) worth $97,076, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in GUTS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 90,529 shares. Largest reduction occurred in Q1 2026, reducing 152,321 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Fractyl Health (GUTS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fractyl Health (GUTS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +7,250 | Add 247.16% | 10,183 | $9.53 |
| Q1 2026 | -152,321 | Reduce 98.11% | 2,933 | $5.49 |
| Q4 2025 | +90,529 | Add 139.87% | 155,254 | $26.40 |
| Q3 2025 | +776,700 | New Buy | 64,725 | $19.08 |
| Q4 2024 | -5,225 | Sold Out | 0 | $0.00 |
| Q3 2024 | +4,042 | Add 341.67% | 5,225 | $30.36 |
| Q2 2024 | +1,183 | New Buy | 1,183 | $51.25 |
Renaissance Technologies (RenTech)'s Fractyl Health Investment FAQs
Renaissance Technologies (RenTech) first purchased Fractyl Health, Inc. (GUTS) in Q2 2024, acquiring 1,183 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Fractyl Health, Inc. (GUTS) for 7 quarters since Q2 2024.
Renaissance Technologies (RenTech)'s largest addition to Fractyl Health, Inc. (GUTS) was in Q3 2025, adding 64,725 shares worth $1.23 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 10,183 shares of Fractyl Health, Inc. (GUTS), valued at approximately $97,076.
As of the Q2 2026 filing, Fractyl Health, Inc. (GUTS) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Fractyl Health, Inc. (GUTS) was 155,254 shares, as reported at the end of Q4 2025.